NASDAQ:MNOV
Medicinova Inc.
Medicinova Inc.'s revenue was $409,657 in fiscal 2025. Free cash flow was −$9.8M, −2395.4% of revenue.Summary generated from Medicinova Inc.'s SEC filings. Latest annual report filed Mar 10, 2026.
Key statistics
Fiscal 2025 from SEC filings. MethodologyRevenue (FY25)$409,657
Revenue growthn/a
Revenue, 5-yr CAGRn/a
Gross marginn/a
Operating margin−3242.5%
Net margin−2928.8%
ROICn/a
Return on equity−25.5%
Debt / equityn/a
Free cash flow−$9.8M
FCF margin−2395.4%
Share count change+0.0%
Financials
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 4 | n/a | 1 | n/a | 0 |
| Operating income | −10 | −15 | −10 | −13 | −13 |
| Net income | −10 | −14 | −9 | −11 | −12 |
| Free cash flow | −9 | −13 | −7 | −11 | −10 |
Recent filings
- 4Insider transaction report
Sep 29, 2026 - 8-KEntry into a material agreement
Sep 28, 2026 - 8-KTermination of a material agreement
Sep 2, 2026 - 8-KDirector or officer change
Aug 19, 2026 - 10-QQuarterly report for the period ended Jun 30, 2026
Aug 13, 2026 - 4Insider transaction report
Jun 25, 2026 - 8-KResults of a shareholder vote
Jun 24, 2026 - 10-QQuarterly report for the period ended Mar 31, 2026
May 14, 2026